Correlation Between MiMedx and Monte Rosa
Can any of the company-specific risk be diversified away by investing in both MiMedx and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MiMedx and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MiMedx Group and Monte Rosa Therapeutics, you can compare the effects of market volatilities on MiMedx and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MiMedx with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of MiMedx and Monte Rosa.
Diversification Opportunities for MiMedx and Monte Rosa
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between MiMedx and Monte is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding MiMedx Group and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and MiMedx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MiMedx Group are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of MiMedx i.e., MiMedx and Monte Rosa go up and down completely randomly.
Pair Corralation between MiMedx and Monte Rosa
Given the investment horizon of 90 days MiMedx Group is expected to generate 0.51 times more return on investment than Monte Rosa. However, MiMedx Group is 1.98 times less risky than Monte Rosa. It trades about 0.07 of its potential returns per unit of risk. Monte Rosa Therapeutics is currently generating about 0.03 per unit of risk. If you would invest 374.00 in MiMedx Group on October 20, 2024 and sell it today you would earn a total of 538.00 from holding MiMedx Group or generate 143.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
MiMedx Group vs. Monte Rosa Therapeutics
Performance |
| Timeline |
| MiMedx Group |
| Monte Rosa Therapeutics |
MiMedx and Monte Rosa Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MiMedx and Monte Rosa
The main advantage of trading using opposite MiMedx and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MiMedx position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.| MiMedx vs. Monte Rosa Therapeutics | MiMedx vs. Design Therapeutics | MiMedx vs. Werewolf Therapeutics | MiMedx vs. Ikena Oncology |
| Monte Rosa vs. Nkarta Inc | Monte Rosa vs. Lyell Immunopharma | Monte Rosa vs. Generation Bio Co | Monte Rosa vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |